Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11239-020-02228-y http://scihub22266oqcxt.onion/10.1007/s11239-020-02228-y C7358286/?report=reader!7358286!32661757     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Thromb+Thrombolysis 2020 ; 50 (3): 587-95 Nephropedia Template TP {{tp|p=32661757|t=2020. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature |pdf=|usr=}}{{32661757}} gab.com Text COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature JO: J Thromb Thrombolysis http://www.kidney.de/pget.php?&tw=1&pmid=32661757 #FOAvip Acute ischemic stroke (AIS) is a life-threatening complication of coronavirus disease 2019 (COVID-19) infection. Increasing reports suggest an association between COVID-19 and AIS, although the underlying mechanism remains uncertain. We performed a systematic review to characterize the clinical characteristics, neuroimaging findings, and outcomes of AIS in COVID-19 patients. A literature search was performed in PubMed and Embase using a suitable keyword search strategy from 1st December 2019 to 29th May 2020. All studies reporting AIS occurrence in COVID-19 patients were included. A total of 39 studies comprising 135 patients were studied. The pooled incidence of AIS in COVID-19 patients from observational studies was 1.2% (54/4466) with a mean age of 63.4?±?13.1 years. The mean duration of AIS from COVID-19 symptoms onset was 10?±?8 days, and the mean NIHSS score was 19?±?8. Laboratory investigations revealed an elevated mean d-dimer (9.2?±?14.8 mg/L) and fibrinogen (5.8?±?2.0 g/L). Antiphospholipid antibodies were detected in a significant number of cases. The majority of AIS neuroimaging patterns observed was large vessel thrombosis, embolism or stenosis (62.1%, 64/103), followed by multiple vascular territory (26.2%, 27/103). A high mortality rate was reported (38.0%, 49/129). We report the pooled incidence of AIS in COVID-19 patients to be 1.2%, with a high mortality rate. Elevated d-dimer, fibrinogen and the presence of antiphospholipid antibodies appear to be prominent in COVID-19 patients with concomitant AIS, but further mechanistic studies are required to elucidate their role in pathogenesis.Electronic supplementary material: The online version of this article (10.1007/s11239-020-02228-y) contains supplementary material, which is available to authorized users. Twit Text FOAVip COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature ????J Thromb Thrombolysis http://www.kidney.de/pget.php?&tw=1&pmid=32661757 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32661757 #FOAvip English Wikipedia <ref>{{Cite pmid|32661757}}</ref> COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature #MMPMID32661757 Tan YK; Goh C; Leow AST; Tambyah PA; Ang A; Yap ES; Tu TM; Sharma VK; Yeo LLL; Chan BPL; Tan BYQ J Thromb Thrombolysis 2020[]; 50 (3): 587-95 PMID32661757show ga Acute ischemic stroke (AIS) is a life-threatening complication of coronavirus disease 2019 (COVID-19) infection. Increasing reports suggest an association between COVID-19 and AIS, although the underlying mechanism remains uncertain. We performed a systematic review to characterize the clinical characteristics, neuroimaging findings, and outcomes of AIS in COVID-19 patients. A literature search was performed in PubMed and Embase using a suitable keyword search strategy from 1st December 2019 to 29th May 2020. All studies reporting AIS occurrence in COVID-19 patients were included. A total of 39 studies comprising 135 patients were studied. The pooled incidence of AIS in COVID-19 patients from observational studies was 1.2% (54/4466) with a mean age of 63.4?±?13.1 years. The mean duration of AIS from COVID-19 symptoms onset was 10?±?8 days, and the mean NIHSS score was 19?±?8. Laboratory investigations revealed an elevated mean d-dimer (9.2?±?14.8 mg/L) and fibrinogen (5.8?±?2.0 g/L). Antiphospholipid antibodies were detected in a significant number of cases. The majority of AIS neuroimaging patterns observed was large vessel thrombosis, embolism or stenosis (62.1%, 64/103), followed by multiple vascular territory (26.2%, 27/103). A high mortality rate was reported (38.0%, 49/129). We report the pooled incidence of AIS in COVID-19 patients to be 1.2%, with a high mortality rate. Elevated d-dimer, fibrinogen and the presence of antiphospholipid antibodies appear to be prominent in COVID-19 patients with concomitant AIS, but further mechanistic studies are required to elucidate their role in pathogenesis.Electronic supplementary material: The online version of this article (10.1007/s11239-020-02228-y) contains supplementary material, which is available to authorized users. äCOVID-19 and ischemic stroke: a systematic review and meta-summary of (epmc).pdf DeepDyve Pubget Overpricing